Jan 27, 2026, 01:01 AM by User Not Found

Bio-IT World | BigHat Biosciences and Revvity have entered collaborations with Eli Lilly and Company; Immunai has signed an agreement with Bristol Myers Squibb; SandboxAQ launches a new AI model; and more.

Jan 26, 2026, 09:01 AM by

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

Jan 23, 2026, 10:47 AM by

Jan 23, 2026, 10:47 AM by

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

Jan 23, 2026, 01:06 AM by User Not Found

Bio-IT World | The mood at this year's J.P. Morgan Healthcare Conference signals a dramatic shift for biopharma dealmaking, with industry leaders projecting 2026 could eclipse last year's surging merger and acquisition activity. During an Endpoints News panel discussion, senior executives from AbbVie, Amgen, and Merck expressed confidence that favorable market conditions and breakthrough science are converging to create what one panelist called "a renaissance moment" for the sector.

Jan 23, 2026, 01:01 AM by User Not Found

Bio-IT World | Applying artificial intelligence (AI) to fragmented and incomplete safety data cannot fill the gap left when the right information has not been captured during initial patient adverse event reporting. And yet, software vendors position the technology as a quick fix to safety data complexity. Although AI definitely has a role to play, it would be far better to use it to refine the data capture process.

Jan 21, 2026, 08:35 AM by

Jan 21, 2026, 08:35 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).

Jan 21, 2026, 08:35 AM by

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

Jan 21, 2026, 08:35 AM by

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

Jan 20, 2026, 08:51 AM by User Not Found

Bio-IT World | The pharmaceutical industry’s approach to artificial intelligence is maturing, with companies increasingly focused on innovation rather than mere efficiency gains. However, significant hurdles around data quality and workforce training continue to impede progress.

Jan 16, 2026, 07:19 AM by

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Jan 16, 2026, 07:19 AM by

Jan 16, 2026, 07:19 AM by

Supports customers with real-time clinical intelligence activation through Viz.ai’s integrated clinical workflows, triggers, and compliant orchestration services for Agentforce.

Jan 15, 2026, 08:43 AM by

Jan 15, 2026, 08:43 AM by

Sapio Sciences has announced a growing partner ecosystem for Sapio ELaiN, its third-generation AI lab notebook, integrating trusted, third-party scientific applications and platforms directly into the workflow. These integrations allow biopharma scientists to use established tools for modeling, analytics and discovery inside ELaiN while maintaining governance, traceability and control.

Jan 15, 2026, 08:43 AM by

Jan 14, 2026, 08:53 AM by

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Jan 14, 2026, 08:53 AM by

Strategic appointment to support global scale-up of sample management operations

Jan 14, 2026, 08:53 AM by